Tissue doppler imaging and plasma BNP levels to assess the prognosis in patients with hypertrophic cardiomyopathy

Journal of the American Society of Echocardiography

Volumn 24, Issue 9, 2011, Pages 1020-1025

  Kitaoka, Hiroaki ^a   Kubo, Toru ^a   Okawa, Makoto ^a   Takenaka, Nana ^a   Sakamoto, Chiyo ^a   Baba, Yuichi ^a   Hayashi, Kayo ^a   Yamasaki, Naohito ^a   Matsumura, Yoshihisa ^a   Doi, Yoshinori L ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

BNP; Doppler tissue imaging; HCM; Prognosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SYNCOPE; TISSUE DOPPLER IMAGING;

CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 80052058114     PISSN: 08947317     EISSN: 10976795     Source Type: Journal    
DOI: 10.1016/j.echo.2011.05.009     Document Type: Article

References (31)

1. B.J. Maron, J.A. Towbin, G. Thiene, C. Antzelevitch, D. Corrado, and D. Arnett Contemporary definitions and classification of the cardiomyopathies Circulation 113 2006 1807 1816
2. P. Elliott, B. Andersson, E. Arbustini, Z. Bilinska, F. Cecchi, and P. Charron Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J 29 2008 270 276
3. A. Kimura Molecular etiology and pathogenesis of hereditary cardiomyopathy Circ J 72 2008 A38 A48
4. B.J. Maron, I. Olivotto, P. Spirito, S.A. Casey, P. Bellone, and T.E. Gohman Epidemiology of hypertrophic cardiomyopathy-related death Circulation 102 2002 858 864
5. F. Cecchi, I. Olivotto, S. Betocchi, C. Rapezzi, M.R. Conte, and G. Sinagra The Italian Registry for Hypertrophic Cardiomyopathy: a nationwide survey Am Heart J 150 2005 947 954 (Pubitemid 41607773)
6. B.J. Maron Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy Circulation 121 2010 445 456
7. H. Kitaoka, T. Kubo, M. Okawa, N. Hitomi, T. Furuno, and Y.L. Doi Left ventricular remodeling of hypertrophic cardiomyopathy: longitudinal observation in a rural community Circ J 70 2006 1543 1549 (Pubitemid 44819867)
8. T. Kubo, H. Kitaoka, M. Okawa, T. Hirota, K. Hayato, and N. Yamasaki Clinical impact of atrial fibrillation in patients with hypertrophic cardiomyopathy Circ J 73 2009 1599 1605
9. S.F. Nagueh, N.M. Lakkis, K.J. Middleton, W.H. Spencer III, W.A. Zoghbi, and M.A. Quinones Doppler estimation of left ventricular filling pressure in patients with hypertrophic cardiomyopathy Circulation 99 1999 254 261 (Pubitemid 29056368)
10. H. Kitaoka, T. Kubo, M. Okawa, T. Hirota, K. Hayato, and N. Yamasaki Utility of tissue Doppler imaging to predict exercise capacity in hypertrophic cardiomyopathy: Comparison with B-type natriuretic peptide J Cardiol 53 2009 361 367
11. G.K. Efthimiadis, G. Giannakoulas, D.G. Parcharidou, H.I. Karvounis, S.T. Mochlas, and I.H. Styliadis Clinical significance of tissue Doppler imaging in patients with hypertrophic cardiomyopathy Circ J 71 2007 897 903 (Pubitemid 46833928)
12. W.H.W. Tang, G.S. Francis, D.A. Morrow, L.K. Newby, C.P. Cannon, and R.L. Jesse National academy of clinical biochemistry medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure Circulation 116 2007 e99 109
13. B.J. Maron, V.N. Tholakanahalli, A.G. Zenovich, S.A. Casey, D. Duprez, and D.M. Aeppli Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy Circulation 109 2004 984 989 (Pubitemid 38282851)
14. B. Mutlu, F. Bayrak, G. Kahveci, M. Fefertekin, E. Eroglu, and Y. Basaran Usefulness of N-terminal pro-B-type natriuretic peptide to predict clinical course in patients with hypertrophic cardiomyopathy Am J Cardiol 98 2006 1504 1506 (Pubitemid 44779482)
15. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, and P.A. Pellikka Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463 (Pubitemid 41821197)
16. M. Okawa, H. Kitaoka, Y. Matsumura, T. Kubo, N. Yamasaki, and T. Furuno Functional assessment by myocardial performance index (Tei index) correlates with plasma brain natriuretic peptide concentration in patients with hypertrophic cardiomyopathy Circ J 69 2005 951 957 (Pubitemid 41124264)
17. S.R. Ommen, R.A. Nishimura, C.P. Appleton, F.A. Miller, Jk Oh, and M.M. Redfield Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressure: a comparative simultaneous Doppler-catheterization study Circulation 102 2000 1788 1794
18. N. Sadoul, K. Prasad, P.M. Elliott, S. Bannerjee, M.P. Frenneaux, and W.J. McKenna Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy Circulation 96 1997 2987 2991 (Pubitemid 27500099)
19. M.S. Maron, I. Olivotto, S. Betocchi, S. Casey, J.R. Lesser, and M.A. Losi Effect of left ventricular outflow tract obstruction in clinical outcome in hypertrophic cardiomyopathy N Engl J Med 348 2003 295 303 (Pubitemid 36119984)
20. R. Anan, G. Greve, L. Thierfelder, H. Watkins, W.J. McKenna, and S. Solomon Prognostic implications of novel β cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy J Clin Invest 1194 93 1995 280 285 (Pubitemid 24030847)
21. I. Olivotto, F. Cecchi, S.A. Casey, A. Dolara, J.H. Traverse, and B.J. Maron Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy Circulation 104 2001 2517 2524 (Pubitemid 33107372)
22. T. Hirota, H. Kitaoka, T. Kubo, M. Okawa, T. Furuno, and Y.L. Doi Morphologic characteristics of hypertrophic cardiomyopathy of the elderly with cardiac myosin-binding protein C gene mutations Circ J 70 2006 875 879 (Pubitemid 43979125)
23. S. Lim, S. Lutucuta, P. Bachireddy, K. Youker, A. Evans, and M. Entman Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy Circulation 103 2001 789-9
24. P. Spirito, C. Autore, C. Rapezzi, P. Bernabo, R. Badagliacca, and M.S. Maron Syncope and risk of sudden death in hypertrophic cardiomyopathy Circulation 119 2009 1703 1710
25. P. Sorajja, R.A. Nishimura, B.J. Gersh, J.A. Dearani, D.O. Hodge, and H.J. Wiste Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: along-term follow-up study J Am Coll Cardiol 54 2009 234 241
26. B.J. Maron, P. Spirito, K.J. Green, Y.E. Wesley, R.O. Bonow, and J. Arce Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 10 1987 733 742 (Pubitemid 17163095)
27. S.F. Naguch, K.J. Middleton, H.A. Kopelen, W.A. Zoghbi, and M.A. Quinones Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures J Am Coll Cardiol 30 1997 1527 1533 (Pubitemid 27486472)
28. K. Nishigaki, M. Tomita, K. Kagawa, T. Noda, S. Minatogichi, and H. Oda Marked expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy J Am Coll Cardiol 28 1998 1234 1242 (Pubitemid 26377000)
29. C. Briguori, S. Betocchi, F. Manganelli, B. Gigante, M.A. Losi, and Q. Ciampi Determinations and clinical significance of natriuretic peptides in hypertrophic cardiomyopathy Eur Heart J 22 2001 1328 1336 (Pubitemid 32737625)
30. A.Q. Araujo, E. Arteaga, B.M. Ianni, P.C. Buck, R. Rabello, and C. Mady Effect of losartan on left ventricular diastolic function in patients with nonobstructive hypertrophic cardiomyopathy Am J Cardiol 96 2005 1563 1567 (Pubitemid 41690179)
31. R. Patel, S.F. Nagueh, N. Tsubouleva, M. Abdellatif, S. Lutucuta, and H.A. Kopelen Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy Circulation 104 2001 317 324 (Pubitemid 32666954)